Podcasts about covid-19: on the frontlines

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Avindra Nath, MD Researchers from the National Institutes of Health (NIH) found that 100 percent of the participants in this study had fatigue and experienced cognitive difficulties. So what can we learn from this new research to help us diagnose and treat patients with disabling neurological symptoms after they had COVID-19? To discuss the findings, Dr. Charles Turck is joined by Dr. Avindra Nath, Clinical Director of the National Institute of Neurological Disorders and Stroke.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Avindra Nath, MD Researchers from the National Institutes of Health (NIH) found that 100 percent of the participants in this study had fatigue and experienced cognitive difficulties. So what can we learn from this new research to help us diagnose and treat patients with disabling neurological symptoms after they had COVID-19? To discuss the findings, Dr. Charles Turck is joined by Dr. Avindra Nath, Clinical Director of the National Institute of Neurological Disorders and Stroke.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jonathan Li, MD, MMSc COVID-19 viral rebound infections continue to impact patients and challenge clinicians. To help us better understand why some patients experience it—and how antiviral medication plays a role—Dr. Charles Turck and Dr. Jonathan Li explore COVID-19 rebound infections and antiviral treatment nirmatrelvir/ritonavir.

Host: Jennifer Caudle, DO Guest: Jennifer Shu, MD, FAAP Why are we currently facing a tripledemic? Joining Dr. Jennifer Caudle to uncover what has led to this dramatic increase in COVID-19, RSV, and the flu—and share strategies to combat this tripledemic—is ReachMD Host Dr. Jennifer Shu, a pediatrician at Children's Medical Group in Atlanta, Georgia.

CME credits: 0.25 Valid until: 13-10-2023 Claim your CME credit at https://reachmd.com/programs/cme/covid-19-updates-on-best-practices-to-improve-outcomes/14091/ Newer therapeutic options are now available to treat COVID-19. Don't panic! Drs. Charles Vega and Paul Auwaerter are here to help you successfully integrate these therapeutics into your practice. Find out how to identify patients that are at risk for severe disease and select the appropriate treatment for the patient in front of you.

CME credits: 0.25 Valid until: 13-10-2023 Claim your CME credit at https://reachmd.com/programs/cme/covid-19-differentiating-disease-course-and-updates-on-treatment/14090/ Clinicians treating patients in outpatient, urgent care, and emergent care settings who encounter patients with mild to moderate disease are tasked with providing optimal care to prevent disease progression. Drs. Charles Vega and David Cennimo take us through the spectrum of COVID-19 disease and identify available treatment options for your high-risk patients.

Host: Charles P. Vega, MD Guest: David J. Cennimo, MD, FACP, FAAP, FIDSA Clinicians treating patients in outpatient, urgent care, and emergent care settings who encounter patients with mild to moderate disease are tasked with providing optimal care to prevent disease progression. Drs. Charles Vega and David Cennimo take us through the spectrum of COVID-19 disease and identify available treatment options for your high-risk patients.

Host: Charles P. Vega, MD Guest: Paul G. Auwaerter, MD, MBA Newer therapeutic options are now available to treat COVID-19. Don't panic! Drs. Charles Vega and Paul Auwaerter are here to help you successfully integrate these therapeutics into your practice. Find out how to identify patients that are at risk for severe disease and select the appropriate treatment for the patient in front of you.

Host: Mario R. Nacinovich, Jr., MSc Guest: Siwen Wang, MD Have our patients experienced anxiety, depression, and stress following a COVID-19 infection? Joining Mario Nacinovich to dive into emerging research on post-COVID-19 psychological distress is Dr. Siwen Wang, a researcher in the Department of Nutrition at Harvard T.H. Chan School of Public Health.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: William Schaffner, MD Before recommending the new COVID-19 booster, what do we need to know about this vaccine, and which of our patients fit the criteria for it? To learn the latest on what experts have to say about the new COVID-19 booster, Dr. Charles Turck speaks with Dr. William Schaffner from the National Foundation for Infectious Diseases.

Host: Peter Buch, MD, FACG, AGAF, FACP The COVID-19 pandemic has entirely transformed the educational community, especially for medical students. To find out more about this impact, Dr. Peter Buch is joined by two fourth-year medical school students, Miss Sheila Eghbali and Mr. Kyle Glose, to discuss their experiences.

Host: Charles Turck, PharmD, BCPS, BCCCP Over the course of the COVID-19 pandemic, the healthcare field has been hit hard—facing employment challenges, increased burnouts, and more. Yet salaries have been slow to rise, and conditions haven't improved. Dr. Thuy Nguyen from the University of Michigan School of Public Health joins Dr. Charles Turck to share how employment in the healthcare field has changed over the course of the COVID-19 pandemic.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Heather Moday, MD When we say the words behavior, diet, habits, and environment, chances are you don't think of the body's immune system. But based on recent research, all of those factors play a role in influencing immune function. So how can we keep them in mind and boost our immunity in the face of prevalent diseases, including COVID-19? Find out with Dr. Charles Turck as he speaks with Dr. Heather Moday, author of The Immunotype Breakthrough: Your Personalized Plan to Balance Your Immune System, Optimize Health, and Build Lifelong Resilience.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Amy McGorry PT, DPT, MTC Guest: Catherine C. Crowley, PhD, CCC-SLP COVID-19 has led to several unexpected challenges, impacting several parts of the body, including our patients' voices. What do we need to know about these impacts to better care for our patients? To answer this question, Drs. Amy McGorry and Catherine Crowley of Long Island University in New York join Dr. Charles Turck to share their clinical experience with vocal fatigue and dysphonia related to COVID-19.

Host: Hector O. Chapa, MD, FACOG Guest: Dani Dumitriu, MD, PhD The COVID-19 pandemic has taken a toll on all patients, especially pregnant women. Here to walk us through her research on the pandemic's impact on the psychosocial health of mothers and the neurodevelopment of their fetuses is Dr. Dani Dumitriu, a pediatrician, neuroscientist, and pediatric environmental health scientist at Columbia University in New York.

Host: John J. Russell, MD Guest: Benjamin Abramoff, MD, MS Once a patient is discharged from the hospital after battling COVID-19, the war they face with this disease may not be over. In fact, many patients continue to experience long-term effects, which is why some institutions have formed clinics that are solely dedicated to caring for these patients. To learn more about how one such clinic is helping patients manage these devastating effects, Dr. John Russell speaks to physiatrist Dr. Benjamin Abramoff from the Post-COVID Assessment and Recovery Clinic at Penn Medicine in Philadelphia.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: William Schaffner, MD From widespread variants to the threat of a twindemic -- what has the COVID-19 pandemic taught us? And can we learn to coexist with this virus? Dr. Charles Turck is joined by Dr. William Schaffner from the National Foundation for Infectious Diseases to discuss what's on the horizon for the pandemic.

Host: Hector O. Chapa, MD, FACOG Guest: Linda Bradley, MD While many people across the country have access to COVID-19 vaccines, there are certain communities where access is not as easy. So what can we do to address the vaccination gaps and barriers to care during the COVID-19 pandemic and beyond? Find out with Dr. Hector Chapa as he speaks with Dr. Linda Bradley from Case Western Reserve University, who shares a brief history of the presence of social determinants of health and racial disparities across our nation and how they impact our current vaccination efforts.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Chris Beyrer, MD, MPH Amid the ongoing COVID-19 pandemic, countries in Sub-Saharan Africa are also facing high rates of HIV and AIDS prevalence. But after the success of the mRNA COVID-19 vaccines, could an mRNA vaccine for HIV/AIDS be on the horizon? Here to explore emerging research and the potential role that mRNA technology might have in battling this global epidemic is Dr. Chris Beyrer, a Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.

Guest: Jeniffer Hernandez, PhD Over 1.5 million viruses could potentially cause a future pandemic. Could antibodies be the key to neutralizing those viruses? Here to share how future vaccination efforts might incorporate neutralizing antibodies and her research on preventing future pandemics is Dr. Jeniffer Hernandez, Associate Professor of Biopharmaceutical Sciences at the Keck Graduate Institute.

Host: John J. Russell, MD Guest: Jessica Malaty Rivera, MS Social media and the ability to quickly spread information across the internet has allowed misinformation surrounding COVID-19 vaccines and the disease itself to spread like wildfire. But the good news is that when armed with effective counseling strategies and data from initiatives like the COVID-19 Tracking Project, we as clinicians can help stop the spread of harmful conspiracies and myths. Joining Dr. John Russell to talk about those essential strategies and the COVID-19 Tracking Project is infectious disease epidemiologist Ms. Jessica Rivera.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Animesh Ray, PhD Getting ahead of the next pandemic may be possible thanks to deep machine learning's ability to predict the structure of antibodies. And while that may sound like science fiction, this technology is currently being studied, which is why Dr. Animesh Ray from the Keck Graduate Institute joins Dr. Charles Turck to provide insight on where the research currently lies and what we have to look forward to.

Host: John J. Russell, MD The global pandemic incited the expedited development of COVID-19 vaccines. But how did that change the development process? ReachMD host and Family Medicine Physician, Dr. John Russell, tells us how the rollout of the COVID-19 vaccine differs from other vaccines and what it could mean for the medical field.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jill Foster, MD From mRNA vaccines to egg-based vaccines, what do we need to know about the different types of vaccines? Dr. Jill Foster, Director of the Division of Pediatric Infectious Diseases and Immunology at the University of Minnesota, joins Dr. Charles Turck to explore what we need to know about the various types of vaccines available.

Host: Jennifer Caudle, DO Guest: Charles P. Vega, MD The development of mRNA vaccines marked a turning point in the battle against the COVID-19 pandemic, but what do we need to know about this emerging vaccine technology? Dr. Jennifer Caudle and Dr. Charles Vega, a Clinical Professor in the Department of Family Medicine at the University of California Irvine, discuss some of the benefits and common concerns.

Guest: Muthiah Vaduganathan, MD, MPH What do we currently know about the cardiac consequences of the COVID-19 vaccines? Dr. Muthiah Vaduganathan, cardiologist and investigator at Brigham Women's Hospital at Harvard Medical School, addresses the cardiac concerns surrounding the vaccines and how we can talk to patients about them.

Host: Mario R. Nacinovich, Jr., MSc Guest: Randy Young, MD Amid the surge of the Delta variant, critical care physician Dr. Randy Young is traveling to ICUs across the country to help treat patients. Tune in to hear Dr. Young share how this surge is impacting both patients infected with the variant and the healthcare professionals caring for them.

Host: Jennifer Caudle, DO Host: John J. Russell, MD “What makes the Delta variant different?” “I keep hearing about breakthrough infections, so are the COVID-19 vaccines effective?” These are just some of the questions patients now have amid the surge of the Delta variant, and many patients are turning to physicians for answers. That's why ReachMD hosts and primary care physicians Drs. Jennifer Caudle and John Russell sit down to share their approach to answering these FAQs regarding the Delta variant, the COVID-19 vaccines, and more.

Host: Jennifer Shu, MD, FAAP Tune in to hear pediatrician Dr. Jennifer Shu share what we currently know about the risks and impacts of the Delta variant on our youngest patients and perhaps even more importantly, how we can help keep them safe. Published September 23, 2021

Host: Jennifer Shu, MD, FAAP School's back in session, and that means it's time we take a look at how we can help keep children safe and healthy both inside and outside the classroom with pediatrician Dr. Jennifer Shu. Published September 21, 2021

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Pradipta Ghosh, MD Artificial intelligence (AI) is rapidly changing how we practice medicine in a variety of ways, especially in the midst of the COVID-19 pandemic. In fact, a recently developed AI model can help us predict the disease course of patients infected with COVID-19, and here to share how that model was developed based on pandemics of the past and how it can be used in the current—and even future—pandemics is Dr. Pradipta Ghosh, Professor of Cellular and Molecular Medicine at UC San Diego.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Alberto Augsten, PharmD During the COVID-19 pandemic, many patients turned to alcohol as a way to cope with this sudden and unprecedented global health crisis, and the rates of alcohol dependency are only continuing to rise according to recent studies. That's why Dr. Charles Turck speaks with board-certified clinical toxicologist Dr. Alberto Augsten to help us better understand the challenges in screening patients for alcohol dependency amid the COVID-19 pandemic and how we can overcome those barriers to get our patients the best—and necessary—treatment. Published August 20, 2021

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Shantanu Nundy, MD, MBA With all of the chaos and changes brought on by the COVID-19 pandemic, it can be easy to focus on the negative impacts of this global health crisis. But for one physician, the same chaos and changes are exactly what forged his unique perspective: one that recognizes the benefits that has come out of the pandemic. Joining Dr. Charles Turck to share why he believes the COVID-19 pandemic has changed healthcare for the better is primary care physician Dr. Shantanu Nundy, author of a recent article published in The Washington Post titled, “A Surprising Pandemic Side Effect: It Has Improved Healthcare.” Published June X, 2021

Guest: Susan Butler-Wu, PhD, D(ABMM), SM(ASCP) Dr. Susan Butler-Wu, Associate Professor of Clinical Pathology and Director of Medical Microbiology at LAC+USC Medical Center, investigates the differences—and highlights the benefits—of PCR versus antigen testing for COVID-19.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Gail Saltz, MD The quarantine blues may have come to an end, but as the country continues to reopen, a whole new set of mental health challenges are just beginning. So how can we help our patients who found comfort in social distancing and mask-wearing mandates navigate this change and return to public places? To find out, Dr. Charles Turck speaks with psychiatrist Dr. Gail Saltz, who discusses the lasting effects of the quarantine blues, how we can help patients who are suffering from anxiety, and more.

Host: Andrew Wilner, MD, FACP, FAAN Guest: William W. Li, MD As the number of new COVID-19 infections continues to decrease and the United States begins to open back up, it's important to note that there are patients who have survived COVID-19 but are still suffering. The newly coined term “COVID long-haulers” refers to those patients who continue to have symptoms even after the acute infection is resolved. Joining Dr. Andrew Wilner to share what we know so far about COVID long-haulers and how we can help them is vascular biologist Dr. William Li.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Chris H. Cooper Can new mask technology made with innovative materials better protect us from the coronavirus? Dr. Charles Turck speaks with Chris Cooper, Chief Science Officer and CEO of Airlock389, on improving mask technology after the supply shortage of masks during COVID-19.

Host: Hector O. Chapa, MD Guest: Robert Owens Carpenter, MD, MPH, FACS, FASMBS Guest: Toni E. Keaton, MD, MPH Dr. Hector Chapa explores barriers in community health with Dr. Robert Carpenter, Director of Wellness at Texas A&M University College of Medicine, and Dr. Toni Keaton, Assistant Clinical Professor of Internal Medicine at Texas A&M College of Medicine.

Host: Jennifer Shu, MD, FAAP Guest: Ramiz Kseri, MD Without an available vaccine, our pediatric patients can transmit COVID-19. With that in mind, how should pediatric practices adapt? Joining Dr. Jennifer Shu to discuss the impact of COVID-19 on pediatric care is Dr. Ramiz Kseri, a dually board-certified Internist and Pediatrician and an Assistant Professor of Clinical Sciences at Florida State University College of Medicine

Host: Jennifer Shu, MD, FAAP Guest: Ramiz Kseri, MD What are some factors leading to disparities in care for our LGBTQ patients, and how do we keep them safe amid the pandemic? Dr. Jennifer Shu is joined by Dr. Ramiz Kseri, an Internist and Pediatrician and an Assistant Professor of Clinical Sciences at Florida State University College of Medicine, to discuss how the LGBTQ community is affected by COVID-19 and other health risks.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ping Zhang, PhD, FAMIA The pandemic continues to wreak havoc across the world, but a new deep learning computer model may have discovered ten potential treatment options to combat COVID-19. Dr. Charles Turck sits down with Dr. Ping Zhang, who leads the Artificial Intelligence in Medicine Lab and a faculty member at the Translational Data Analytics Institute at The Ohio State University, to discuss his team's findings. Published March 29, 2021

Host: Jennifer Caudle, DO Guest: John J. Russell, MD As clinicians on the frontlines of the COVID-19 pandemic, we're among the first to hear about our patients' fears of the vaccines' validity and safety. So how can we help address their concerns? ReachMD hosts Dr. Jennifer Caudle and Dr. John Russell sit down together to talk about how we can counsel patients who may be hesitant to receive the COVID-19 vaccine. Published March 16, 2021

Host: Jennifer Caudle, DO Guest: Paul Jarris, MD, MBA Since the COVID-19 vaccines received an emergency use authorization, tracking possible adverse reactions in real time becomes even more important. But what are some of the limitations we're facing in doing so, and how can we overcome them? To find out, Dr. Jennifer Caudle speaks with Dr. Paul Jarris, Chief Medical Advisor for MITRE Corporation.

Host: Jennifer Caudle, DO Guest: Anjali Patwardhan, MD In pediatric patients, can the influenza and pneumococcal vaccines impact the COVID-19 disease course? Dr. Jennifer Caudle joins Dr. Anjali Patwardhan, a pediatric rheumatologist at the University of Missouri Healthcare, to discuss COVID-19 in pediatric patients who've been vaccinated for influenza and pneumococcal. Published March 16, 2021

Host: Matt Birnholz, MD Dr. Matt Birnholz reviews more nominees for our Heroes in Healthcare program and what their peers have to say about their efforts.

Host: Matt Birnholz, MD In celebration of our “Heroes in Healthcare,” Dr. Matt Birnholz continues to commend our nominees for their valuable contributions to the field of medicine, taking strides to save lives and make a difference during the COVID-19 pandemic.

Host: Matt Birnholz, MD In honor of our “Heroes in Healthcare” initiative, Dr. Matt Birnholz recounts some of the many healthcare professionals nominated by their peers who've bravely helped their patients combat the COVID-19 pandemic.

Guest: John J. Russell, MD With so many COVID-19 vaccines in development, new medical ethical questions have been brought to the forefront of the healthcare field. With that in mind, Dr. John Russell takes us through the history of ethics and vaccinations throughout the world. Published January 4, 2021

Guest: Dr. Richard Weller Initially viewed as a respiratory, flu-like illness, COVID-19 has increasingly shown to have more devastating effects on cardiovascular health. But with more studies exploring the link between UV rays and heart health, can sunlight reduce COVID-19 deaths? Dr. Richard Weller, a Professor of Dermatology at the University of Edinburgh in Scotland, discusses the details of his latest study on the connection between sunlight and COVID-19 deaths. Published December 7, 2020

Guest: Abigail T. Berman, MD, MSCE The risk of COVID-19 has become a significant factor to consider when selecting between SBRT and surgery for patients with early-stage lung cancer. Dr. Abigail Berman, a radiation oncologist at the University of Pennsylvania Abramson Cancer Center in Philadelphia, discusses how she works with patients to decide on the best treatment for them.